INTRODUCTION—Cerebral vein and dural sinus thrombosis (CVT) is less common than
most other types of stroke but can be more challenging to diagnose. Due to the widespread …

Cerebral venous and sinus thrombosis (CVST) after adenovirus-vectored COVID-19
ChAdOx1 nCov-19 (Oxford–AstraZeneca) and Ad26. COV2. S (Janssen/Johnson & …

Objectives To investigate the risk factors and predictors of outcomes in a cohort of Chinese
patients with cerebral venous sinus thrombosis (CVST), so as to provide a reference for …

Despite the continuous description of new conditions pre‐disposing for cerebral venous
thrombosis (CVT), no apparent cause is found in about 30% of cases …

Background: The COVID-19 pandemic is being battled via the largest vaccination campaign
in history, with more than eight billion doses administered thus far. Therefore, discussions …

Cerebral venous thrombosis (CVT) is rare and has a wide spectrum of symptoms, therefore it
is difficult to diagnose. Thrombosis of the deep cerebral veins occurs very rarely: it has been …

Purpose: Cerebral venous sinus thrombosis (CVST) is a disease with potentially serious
consequences and usually affecting young to middle aged people. This study was designed …

For many years, anticoagulants have been used in the emergent treatment of patients with
acute ischemic stroke. Anticoagulants are prescribed in an effort to prevent first or recurrent …

Cerebral venous thrombosis (CVT) is an uncommon cause of stroke with the incidence of
0.5% from all strokes. The clinical presentation with cerebral hemorrhage constitutes a …

Materials and Methods: A retrospective study of 181 patients with CVST was conducted in a
tertiary care hospital. Results: Of 181 patients (age range 14–96 years, mean age …